Teva Pharmaceutical Industries Limited (TLV:TEVA)

TLV:TEVA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	68,705	91,081	42,146	35,617	27,480	34,000
Market Cap Growth	12.29%	116.11%	18.33%	29.61%	-19.18%	-8.03%
Enterprise Value	122,787	150,359	109,242	106,456	99,359	115,222
Last Close Price	60.70	81.01	38.15	32.99	26.95	30.55
PE Ratio	-	-	-	-	21.19	-
PS Ratio	1.11	1.51	0.74	0.68	0.56	0.64
PB Ratio	2.94	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	24.12	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	14.57	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	2.08	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	7.53	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	10.11	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	43.11	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.70	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.69	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	22.14	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.35	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.46	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.03	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	-19.11%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.27%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.44%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	-6.97%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	4.15%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-1.23%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-1.23%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.